Sarepta therapeutics announces proposed $500,000,000 public offering of common stock

Cambridge, mass., oct. 12, 2021 (globe newswire) -- sarepta therapeutics, inc. (nasdaq:srpt), the leader in precision genetic medicine for rare diseases, today announced that it is offering to sell, subject to market and other conditions, $500,000,000 in shares of its common stock in an underwritten public offering. sarepta also intends to grant the underwriters a 30-day option to purchase up to an additional $75,000,000 in shares of its common stock.
SRPT Ratings Summary
SRPT Quant Ranking